Dechra Pharmaceuticals PLC
ISIN GB0009633180
Dechra Pharmaceuticals PLC has no current public net short positions above the disclosure threshold. The last disclosure was by Qube Research & Technologies Limited of 0.00% on 2024-01-17, reported to FCA.
As of 13 July 2026, the UK Financial Conduct Authority (FCA) no longer publishes net short position disclosures following a change to its reporting rules. The information on this page is therefore outdated and reflects only a snapshot of positions as at 13 July 2026.
Total net short positions over time
Previous position holders
No current positions above the disclosure threshold. Most recent disclosures per holder:
- Qube Research & Technologies Limited0.00%2024-01-17
- AQR Capital Management LLC0.49%2023-06-05
- WorldQuant LLC0.49%2023-04-20
- GLG Partners LP0.38%2023-04-14
- SFM UK Management LLP0.46%2020-05-12
- Polar Capital LLP0.46%2020-03-19
- Jupiter Investment Management Limited0.47%2020-01-06
- AHL Partners LLP0.49%2019-05-22
- BlackRock Institutional Trust Company National Association0.47%2019-03-15
- Systematica Investments Limited0.49%2019-03-04
Data is sourced from the Financial Conduct Authority, which publishes net short position disclosures on its public, free-to-access website. ShortsInsights.com republishes this information for convenience and may apply formatting, grouping, and cleaning that can introduce differences from the source. Data may be delayed, incomplete, or inaccurate, and may not reflect the most recent filings or corrections.
ShortsInsights.com is provided "as is" for informational purposes only and does not constitute investment, legal, or other advice. Users should verify any information directly with the Financial Conduct Authority before making decisions. ShortsInsights.com and its operators disclaim liability for errors, omissions, or actions taken in reliance on the information to the fullest extent permitted by law.